<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS158021</article-id><article-id pub-id-type="doi">10.1101/2022.11.30.518502</article-id><article-id pub-id-type="archive">PPR578933</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Perturbation of the mitochondrial import machinery by aggregation prone Tau affects organelle morphology and reduces neuronal complexity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Needs</surname><given-names>Hope I</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wilkinson</surname><given-names>Kevin A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Henley</surname><given-names>Jeremy M</given-names></name><xref ref-type="corresp" rid="CR1">†</xref></contrib><contrib contrib-type="author"><name><surname>Collinson</surname><given-names>Ian</given-names></name><xref ref-type="corresp" rid="CR1">†</xref></contrib></contrib-group><aff id="A1">School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK</aff><author-notes><corresp id="CR1">
<label>†</label>corresponding authors: <email>ian.collinson@bristol.ac.uk</email> and <email>J.M.Henley@bristol.ac.uk</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>04</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>01</day><month>12</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Protein import into mitochondria is an intricate and highly conserved process essential for organellar biogenesis, and maintenance of its structure and function. Defects in the import apparatus impact the assembly of the respiratory chain and ATP synthase complexes required for oxidative phosphorylation, compromising the supply of ATP to the cytosol. The consequences of reduced bioenergetic function are particularly severe for cells with high energetic demands, such as neurons. However, relatively little is known about how defective import contributes to neurodegeneration, or how aggregation prone toxic proteins, characteristic of neurodegenerative disease, impact mitochondrial import efficiency. Here, we used HeLa cells to investigate how expressing Tau, or a disease-causing variant, affects mitochondrial import activity, morphology, and function. We found that a variant associated with frontotemporal dementia (Tau<sup>P301L</sup>), but not the native version, colocalises with mitochondria, associating with TOM40–the protein-channel component of the outer membrane import complex. Interestingly, Tau<sup>P301L</sup> production had no discernible effect on overall mitochondrial import function, despite associating with TOM40 and altering mitochondrial morphology. This raised suspicions of a rescue mechanism manifested by the appearance of microtubule and actin containing tunnelling nanotubes (TNTs), used to recruit healthy mitochondria from neighbouring cells and/ or dispose of mitochondria containing aggregated Tau. Furthermore, in primary neuronal cultures Tau<sup>P301L</sup> induces morphological changes that resemble a neurodegeneration-like phenotype–also mirrored in cells where the import sites are blocked artificially. These results reveal an intriguing link between the production of aggregation prone protein variants, such as Tau<sup>P301L</sup> and others, with the mitochondrial protein import machinery relevant to neurodegenerative disease.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Mitochondrial protein import is a highly conserved process by which most mitochondrial proteins are transported from where they are synthesised in the cytosol. The process occurs through various pathways ensuring delivery to the desired localisation within the mitochondrion. The translocase of the outer membrane (TOM) complex acts as the major gate for entry into the intermembrane space (IMS). It consists of assembly/stability subunits (TOM5, TOM6, and TOM7), receptor subunits (TOM20, TOM22, and TOM70), and a central pore forming subunit (TOM40) (<xref ref-type="bibr" rid="R9">Chacinska et al., 2009</xref>; <xref ref-type="bibr" rid="R56">Tucker &amp; Park, 2019</xref>). Proteins traversing through TOM40 are then dispersed <italic>via</italic> distinct pathways, depending on their structure, function, and target destination (<xref ref-type="bibr" rid="R9">Chacinska et al., 2009</xref>). The pre-sequence pathway is used by precursor proteins with cleavable N-terminal mitochondrial targeting sequences (MTS). These proteins are either laterally inserted into, or transported across, the inner mitochondrial membrane (IMM); respectively, through the translocase of the inner membrane sort (TIM23<sup>SORT</sup>) or motor (TIM23<sup>MOTOR</sup>) complexes. Cleavage of the MTS enables release and folding of the mature protein (<xref ref-type="bibr" rid="R9">Chacinska et al., 2009</xref>).</p><p id="P3">These pathways (recently reviewed in refs. (<xref ref-type="bibr" rid="R3">Bar-Ziv et al., 2020</xref>; <xref ref-type="bibr" rid="R28">Harbauer et al., 2014</xref>; <xref ref-type="bibr" rid="R44">Needs et al., 2021</xref>)) need to be tightly regulated, and subject to quality control, to maintain mitochondrial structure and function – required for the supply of energy (ATP), cellular homeostasis, and overall health (<xref ref-type="bibr" rid="R51">Sokol et al., 2014</xref>). Mitochondrial dysfunction is one hallmark of neurodegeneration, which is being increasingly linked to failure of the protein import machinery (<xref ref-type="bibr" rid="R36">Lin &amp; Beal, 2006</xref>; <xref ref-type="bibr" rid="R49">Schon &amp; Przedborski, 2011</xref>). For instance, accumulated amyloid precursor protein (APP) within mitochondria from patients with Alzheimer’s disease interacts with the protein-channel components of both outer and inner membranes: TOM40 and TIM23 (<xref ref-type="bibr" rid="R19">Devi et al., 2006</xref>). Similarly, mitochondria isolated from the brains of people affected by Huntington’s disease are decorated with the aggregation prone variant of the Huntingtin protein (Htt). Again, Htt associates with the TIM23 complex and was shown to inhibit import as a result (<xref ref-type="bibr" rid="R60">Yano et al., 2014</xref>).</p><p id="P4">Neurofibrillary tangles (NFTs) comprise insoluble aggregations made up primarily of hyperphosphorylated Tau protein. NFTs are characteristic of Alzheimer’s disease, as well as of all other primary and secondary tauopathies (<xref ref-type="bibr" rid="R54">Tapia-Rojas et al., 2019</xref>). Tau is highly abundant in neurons and is mostly localised in axons, where it binds to microtubules, promoting their assembly and stability (<xref ref-type="bibr" rid="R5">Binder et al., 1985</xref>; <xref ref-type="bibr" rid="R7">Black et al., 1996</xref>; <xref ref-type="bibr" rid="R59">Witman et al., 1976</xref>). Upon binding to microtubules, Tau modulates the activity of the motor proteins Dynein and Kinesin, which in turn regulates the axonal transport of cargo including mitochondria (<xref ref-type="bibr" rid="R11">Chaudhary et al., 2018</xref>; <xref ref-type="bibr" rid="R21">Dixit et al., 2008</xref>; <xref ref-type="bibr" rid="R22">Ebneth et al., 1998</xref>; <xref ref-type="bibr" rid="R39">Mandelkow et al., 2004</xref>; <xref ref-type="bibr" rid="R52">Stamer et al., 2002</xref>). However, the ability of Tau to bind microtubules is a highly dynamic process and is dependent on different Tau isoforms, mutations, and post-translational modifications. Due to the vital role of Tau in axonal migration, its aberrant behaviour can bring about neurological pathogenesis (<xref ref-type="bibr" rid="R2">Avila et al., 2004</xref>; <xref ref-type="bibr" rid="R4">Barbier et al., 2019</xref>; <xref ref-type="bibr" rid="R27">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="R53">Szabo et al., 2020</xref>). The Tau<sup>P301L</sup> variant is commonly found in patients with tauopathies and has been well characterised in disease models (<xref ref-type="bibr" rid="R24">Goedert &amp; Jakes, 2005</xref>; <xref ref-type="bibr" rid="R46">Poorkaj et al., 2001</xref>). Critically, Tau<sup>P301L</sup> is known to have an increased propensity to form NFTs (<xref ref-type="bibr" rid="R41">Murakami et al., 2006</xref>).</p><p id="P5">Mitochondrial function is impaired by abnormal, pathological Tau, but the mechanism is not yet fully understood. The accumulation of Tau into NFTs can elicit several specific mitochondrial effects. These include increased retrograde transport of mitochondria (<italic>i.e.</italic>, towards the soma); reduced complex I activity, ATP levels, and membrane potential; enhanced oxidative stress; and defective mitophagy (<xref ref-type="bibr" rid="R29">Hu et al., 2016</xref>; <xref ref-type="bibr" rid="R33">Lasagna-Reeves et al., 2011</xref>; <xref ref-type="bibr" rid="R35">Li et al., 2016</xref>; <xref ref-type="bibr" rid="R52">Stamer et al., 2002</xref>). Furthermore, various studies have shown that aggregation prone Tau accumulates within the IMS and OMM (<xref ref-type="bibr" rid="R14">Cieri et al., 2018</xref>; <xref ref-type="bibr" rid="R29">Hu et al., 2016</xref>). Tau mitochondrial accumulation and alterations in membrane potential suggest that there may also be import defects, since membrane potential is required for translocation of proteins across the IMM. However, no studies have yet directly examined import in the presence of pathological Tau.</p><p id="P6">Here, we show that the disease-linked variant, Tau<sup>P301L</sup>, interacts with the channel forming subunit of the TOM complex (TOM40). Tau<sup>P301L</sup> association with TOM40 corresponds to changes in mitochondrial morphology together with a reduction in neuronal complexity. Interestingly, these changes to neuronal structure were also induced when mitochondrial import sites were artificially blocked. This suggests that perturbation of mitochondrial protein import, specifically by blockage of the TOM channel by variants of Tau or other aggregation prone proteins, may be an important factor in the onset of neurodegenerative diseases.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>The aggregation prone variant Tau<sup>P301L</sup> associates with the mitochondrial import machinery</title><p id="P7">The association of Tau variants with mitochondria was investigated in HeLa cells conditioned with galactose (HeLaGAL); galactose impairs glycolytic metabolism and drives cells to be more dependent on mitochondria for their energy supplies (<xref ref-type="bibr" rid="R1">Aguer et al., 2011</xref>). We expressed Myc-Tau<sup>WT</sup>, Myc-Tau<sup>P301L</sup>, or a GFP control in these cells and carried out Western blotting analysis on the fractionated mitochondria and cytosol (<xref ref-type="fig" rid="F1">Fig. 1A</xref>, left panel). The results show that in Myc-Tau<sup>P301L</sup> containing cells there was a higher proportion of the Tau protein localised to mitochondria compared to those expressing Myc-Tau<sup>WT</sup> or GFP (<xref ref-type="fig" rid="F1">Fig. 1A</xref>, left panel – quantified in 1B). To test whether the increased mitochondrial localisation of Tau<sup>P301L</sup> correlates with altered import pathway components, we expanded this analysis to include a selection of subunits of the import machinery (<xref ref-type="fig" rid="F1">Fig. 1A</xref>, right panel – quantified in 1C). Overall, mitochondria from cells overexpressing Tau<sup>P301L</sup> had lower levels of mitochondrial TOM20 (receptor subunit of the TOM complex of the OMM) and TIM23 (channel forming subunit of the TIM23 complex in the IMM) compared to control cells, but there was no change in abundance of TOM40 (channel forming subunit of TOM complex of the OMM). Together, these data are indicative of mitochondrial import defects induced by Tau<sup>P301L</sup>.</p><p id="P8">Next, we investigated the interaction between Tau<sup>P301L</sup> and the translocation machinery. We used Myc-trap pull-down assays on mitochondria isolated from cells producing recombinant Myc-GFP, Myc-Tau<sup>WT</sup>, or Myc-Tau<sup>P301L</sup>. Western blots showed that Tau<sup>P301L</sup>, but not its native counterpart or the GFP control, enabled the recovery of detectable quantities of TOM40 (but not TIM23 or TOM20) from the mitochondria of HeLaGAL cells (<xref ref-type="fig" rid="F1">Fig. 1D</xref>; <xref ref-type="supplementary-material" rid="SD1">S1</xref>). This is consistent with previous reports that showed Tau<sup>P301L</sup> accumulation in the OMM and IMS (<xref ref-type="bibr" rid="R14">Cieri et al., 2018</xref>; <xref ref-type="bibr" rid="R29">Hu et al., 2016</xref>), and suggests that it may be associated with the translocation channel in a similar way to an artificially trapped precursor protein (<xref ref-type="bibr" rid="R10">Chacinska et al., 2003</xref>; <xref ref-type="bibr" rid="R23">Ford et al., 2022</xref>; <xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). Surprisingly, however, despite association of Tau<sup>P301L</sup> with the import machinery, in-cell NanoLuc import assays (<xref ref-type="bibr" rid="R42">Hope I. Needs et al., 2022</xref>) showed that the import kinetics of a precursor reporter were not significantly affected (<xref ref-type="fig" rid="F1">Fig. 1E</xref>; <xref ref-type="supplementary-material" rid="SD1">S2</xref>).</p><p id="P9">Analysis of mitochondrial branching showed that cells expressing Tau<sup>P301L</sup> have, on average, significantly fewer branches per mitochondrial network when compared to mitochondria from cells expressing Tau<sup>WT</sup> or GFP (3.9 compared to 5.9 and 6.6, respectively; <xref ref-type="fig" rid="F1">Fig. 1F, G</xref>). The maximum number of branches per network was also reduced to 127.3 for Tau<sup>P301L</sup>, compared to 276.9 for Tau<sup>WT</sup> and 298.3 for GFP (<xref ref-type="fig" rid="F1">Fig. 1H</xref>). Mitochondrial stress tests measuring oxygen consumption and membrane potential (TMRM fluorescence), showed that despite Tau<sup>P301L</sup> induced alterations in mitochondrial morphology, respiratory capacity was unaffected (<xref ref-type="supplementary-material" rid="SD1">Fig. S3</xref>; <xref ref-type="supplementary-material" rid="SD1">S4</xref>).</p></sec><sec id="S4"><title>Tau<sup>P301L</sup> overproduction induces TNT formation</title><p id="P10">In a parallel study, we explored the effects of artificially blocking the import machinery (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). This can be achieved with the small molecule inhibitor MB20 (<xref ref-type="bibr" rid="R13">Cheung, 2017</xref>), or with a precursor fused to DHFR which, when bound to methotrexate, becomes trapped in the channel (<xref ref-type="bibr" rid="R10">Chacinska et al., 2003</xref>; <xref ref-type="bibr" rid="R23">Ford et al., 2022</xref>). While these treatments inhibit import in isolated mitochondria (<xref ref-type="bibr" rid="R13">Cheung, 2017</xref>; <xref ref-type="bibr" rid="R23">Ford et al., 2022</xref>), we unexpectedly found that they fail to do so within whole cells (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). We wondered if the apparent lack of effect on the whole mitochondrial population of the cell could be explained by a mitochondrial replacement system. We found that, at the whole cell level, defective mitochondrial function is rescued by the recruitment of healthy mitochondria from surrounding cells, and disposal of compromised mitochondria, by way of TNTs (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). Therefore, we were curious if the association of the Tau variant with the import apparatus induced a similar response.</p><p id="P11">HeLa cells co-expressing mCherry with either Myc-GFP, Myc-Tau<sup>WT</sup>, or Myc-Tau<sup>P301L</sup> were analysed by confocal microscopy. The results show that in mitochondrial dependent HeLaGAL cells (conditioned with galactose) production of Myc-Tau<sup>P301L</sup> induced TNTs: 62% of all cells exhibited TNTs, compared to 22% of cells producing native Tau and 18% of those expressing GFP (<xref ref-type="fig" rid="F2">Fig. 2A, B</xref>). In contrast, glycolytic HeLaGLU cells (cultured in glucose containing media) were significantly less prone to TNT production. These observations could explain why the association of Tau<sup>P301L</sup> with the import machinery has no impact on protein import activity, due the existence of a TNT-dependent rescue mechanism replacing defective mitochondria in the Tau<sup>P301L</sup> expressing cells. Consistent with this hypothesis, we observed mitochondria inside the TNTs (<xref ref-type="fig" rid="F2">Fig. 2C</xref>), potentially on their way to rescue Tau affected cells.</p><p id="P12">TNTs induced by import impairment contain actin as well as microtubules, which are necessary for mitochondrial movement (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). Thus, drugs that target actin (cytochalasin D) and tubulin (nocodazole) polymerisation inhibit TNT formation (<xref ref-type="bibr" rid="R6">Bittins &amp; Wang, 2017</xref>; <xref ref-type="bibr" rid="R30">Kumar et al., 2017</xref>; <xref ref-type="bibr" rid="R38">Luchetti et al., 2012</xref>). The TNTs induced here also contain actin and tubulin and their drug response is the same (<xref ref-type="fig" rid="F2">Fig. 2D</xref>; <xref ref-type="supplementary-material" rid="SD1">S5</xref>). Therefore, perturbation of the import machinery by precursor trapping, small molecule inhibition (shown previously (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>)) and, as we show here, aggregation of Tau all seem to induce a common response involving TNTs.</p></sec><sec id="S5"><title>The overproduction of Tau<sup>P301L</sup> and precursor trapping both bring about reduced neuronal complexity</title><p id="P13">Next, we explored the effects of perturbing the mitochondrial import machinery in neurons. In particular, we wanted to compare the effects of precursor trapping (deploying a precursor-DHFR fusion in the presence of MTX) against production of Tau<sup>P301L</sup>. We used confocal microscopy to assess morphology of DIV21 (21 days <italic>in vitro</italic>) primary hippocampal neurons following 7 days of precursor trapping or Tau variant over-production. DIV21 neurons equate to ‘mature’ neurons with spines and fully formed synapses (<xref ref-type="bibr" rid="R25">Grabrucker et al., 2009</xref>; <xref ref-type="bibr" rid="R32">LaBarbera et al., 2021</xref>) and therefore allow analysis of synapses and neuronal complexity. Axons were identified by staining for Ankyrin G, a scaffolding protein important in formation of the initial segment of the axon (<xref ref-type="bibr" rid="R26">Grubb &amp; Burrone, 2010</xref>).</p><p id="P14">Over-production of native Tau caused a significant reduction in the number of processes per cell compared to the GFP control, while expression of the aggregation prone Tau<sup>P301L</sup> caused a more pronounced reduction in processes (<xref ref-type="fig" rid="F3">Fig. 3A, B</xref>). Interestingly, despite the reduction in neuronal complexity, neither Tau variant affected axonal length (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). To determine if these effects were attributable to perturbation of the import machinery by Tau, we also subjected primary neurons to mitochondrial precursor trapping. Inclusion of the precursor alone did not affect cell complexity, but when the import of this precursor was stalled by MTX addition, the number of processes was significantly reduced (<xref ref-type="fig" rid="F3">Fig. 3D, E</xref>), mirroring the effect of Tau. In addition, however, stalling import significantly reduced axonal length (<xref ref-type="fig" rid="F3">Fig. 3F</xref>; +MTS, +MTX), suggesting a more severe response. Importantly, the changes in length and complexity were not due to non-specific effects of MTX, as they are dependent on the MTS (<xref ref-type="fig" rid="F3">Fig. 3E, F</xref>; -MTS, ±MTX). Neuronal viability was unaffected by precursor trapping (±MTS) or production of Tau variants, although there was a measurable effect of the methotrexate drug, which is inconsequential for this analysis (<xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref>).</p><p id="P15">These results indicate that a reduction in neuronal complexity and length is brought about by perturbation of the mitochondrial protein import machinery. Notwithstanding the differing response to axonal length, this morphological change can be induced either by artificial precursor stalling, or Tau<sup>P301L</sup> expression, which we assume is mediated <italic>via</italic> a common mechanism.</p></sec><sec id="S6"><title>Precursor trapping and Tau<sup>P301L</sup> correlate with fewer synapses</title><p id="P16">The neuronal analysis was expanded to investigate the number of synapses per dendrite. The major scaffold protein PSD95 is involved in the organisation of excitatory postsynaptic signalling complexes in neurons (<xref ref-type="bibr" rid="R8">Broadhead et al., 2016</xref>), and is therefore commonly used as a postsynaptic marker. These signalling complexes comprise glutamate receptors, ion channels, signalling enzymes and adhesion proteins vital in neurotransmission (<xref ref-type="bibr" rid="R12">Chen et al., 2011</xref>).</p><p id="P17">Imaging and PSD95 staining showed that neurons producing Tau<sup>P301L</sup> contained on average of 1.8 synapses per 10 μm dendrite, significantly lower than cells expressing GFP or native Tau, both of which had about twice as many (<xref ref-type="fig" rid="F4">Fig. 4A, B</xref>). Subsequent Western blotting analysis of whole lysates from cortical cells expressing GFP, or either of the Tau variants, determined that there was no change in the overall abundance of the synaptic markers PSD95, Gephyrin, or Synaptophysin (<xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). This indicates that the noted reduction in synapse abundance, must be due to a change in the distribution of the synaptic assembly protein PSD95 (and possibly others), rather than its quantity.</p><p id="P18">Perturbation of the import machinery by precursor trapping induced an almost identical reduction in the number of synapses per dendrite to expression of Tau<sup>P301L</sup> (<xref ref-type="fig" rid="F4">Fig. 4C, D</xref>). Again, the controls show that synaptic loss is correlated to the precursor trapping and not MTX treatment, since in the absence of a presequence (−MTS) there is no significant change in the number of synapses in the presence of MTX (<xref ref-type="fig" rid="F4">Fig. 4D</xref>, −MTS, ±MTX). Western blotting analysis showed that the overall cellular abundance of all three synaptic marker proteins remained constant irrespective of precursor trapping (<xref ref-type="supplementary-material" rid="SD1">Fig. S8</xref>), as noted above for the Tau variants. These results demonstrate that expression of aggregation prone Tau<sup>P301L</sup>, which binds specifically to the mitochondrial import machinery, produces defects in neuronal complexity and synapse number similar to those observed upon direct blockade of import.</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P19">This study explores aspects of the mitochondrial and cellular responses to Tau, specifically aggregation prone Tau<sup>P301L</sup> that is implicated in neurodegeneration. We established that association of Tau<sup>P301L</sup> with the mitochondrial protein import machinery correlates with disease-like phenotypic changes in mitochondria and neurons. Moreover, the effects of Tau mirror those elicited by a precursor protein artificially stalled within the import machinery by a C-terminal fusion of DHFR bound to methotrexate (MTX), suggesting that Tau<sup>P301L</sup> exerts its effects through perturbation of the mitochondrial import machinery.</p><p id="P20">At the mitochondrial level, import perturbation by various means cause similarly profound morphological changes including decreased branching (Tau aggregation) and increased fission (precursor trapping) (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). Unexpectedly, however, neither Tau<sup>P301L</sup> nor precursor trapping affected overall mitochondrial import activity. We postulate that this can be explained by both Tau<sup>P301L</sup> and precursor trapping inducing the formation of actin and tubulin containing tunnelling nanotubes (TNTs) (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). It has been shown in several previous studies that TNTs can provide a conduit for exchange of mitochondria between cells (summarised in a recent review (<xref ref-type="bibr" rid="R37">Liu et al., 2021</xref>)). Thus, we propose that healthy mitochondria are recruited to damaged cells <italic>via</italic> TNTs from nearby unaffected/ healthy cells. Meanwhile, damaged mitochondria are likely disposed of also through TNTs, as we recently showed following precursor trapping (<xref ref-type="bibr" rid="R42">Hope I Needs et al., 2022</xref>). This process could also provide a rescue mechanism that explains the observed preservation of mitochondrial import activity and respiratory function despite Tau<sup>P301L</sup> accumulation within the TOM40 import channel.</p><p id="P21">The Tau variant induced neuronal changes seen here recapitulate those observed after precursor trapping, strongly suggesting that they occur, at least in part, as a result of perturbation of the import machinery. In this context, we do not yet know if the TNT-dependent rescue response, noted in mitochondria dependent HeLa cells, occurs in neurons. Although we do know that neurons form TNTs, which have been shown to transport Tau itself (<xref ref-type="bibr" rid="R55">Tardivel et al., 2016</xref>). Perhaps the rescue mechanism described incorporates, in addition to inter-cellular mitochondrial sorting, routes for the clearance of pathological proteins from critical cells like neurons.</p><p id="P22">The decrease in processes and synapse number induced by perturbation of the import machinery are consistent with changes observed in neurodegeneration (<xref ref-type="bibr" rid="R15">Coleman &amp; Perry, 2002</xref>; <xref ref-type="bibr" rid="R31">Kweon et al., 2017</xref>; <xref ref-type="bibr" rid="R58">Wishart et al., 2006</xref>). Therefore, an important future goal is to determine if the TNT rescue mechanism is implemented in neurons exposed to import defects, and if so to what extent it mitigates against more severe neuronal aberrations, or cell death. Indeed, the absence of an impact of Tau<sup>P301L</sup>, or precursor trapping, on cell viability may have been due to the rescue process.</p><p id="P23">The variant Tau<sup>P301L</sup> has been extensively characterised (<xref ref-type="bibr" rid="R24">Goedert &amp; Jakes, 2005</xref>; <xref ref-type="bibr" rid="R41">Murakami et al., 2006</xref>; <xref ref-type="bibr" rid="R46">Poorkaj et al., 2001</xref>) and, in agreement with the results shown here, it has previously been shown to localise to the mitochondrial IMS and OMM (<xref ref-type="bibr" rid="R14">Cieri et al., 2018</xref>; <xref ref-type="bibr" rid="R29">Hu et al., 2016</xref>). However, its interaction with the translocation machinery had not previously been reported. Nonetheless, its association with mitochondrial translocases is reminiscent of other proteins implicated in neurodegeneration, such as APP, Huntingtin, and alpha-synuclein (<xref ref-type="bibr" rid="R19">Devi et al., 2006</xref>; <xref ref-type="bibr" rid="R20">Devi et al., 2008</xref>; <xref ref-type="bibr" rid="R60">Yano et al., 2014</xref>). Therefore, the neuronal effects of import perturbation shown here point to a common mechanism that could be an important underlying factor in multiple neurological diseases. Indeed, recent reports have linked failed import or aggregation of proteins within import sites with neurodegenerative diseases: both aggregation prone APP and a disease-associated Huntingtin protein variant become trapped in import sites and are directly correlated with mitochondrial dysfunction, a characteristic feature of neurodegeneration (<xref ref-type="bibr" rid="R19">Devi et al., 2006</xref>; <xref ref-type="bibr" rid="R60">Yano et al., 2014</xref>).</p><p id="P24">The exact mechanism linking import perturbation and the neuronal irregularities, including the role of TNTs and rescue, remains unclear. Nevertheless, the evidence suggests that our artificial trapping substrate is indeed mimicking what is seen in disease. Therefore, it provides us with a useful tool to better understand import dysfunction as a potential contributory factor in the onset of neurodegenerative disease. Moreover, deeper analysis of the potential TNT-mediated rescue mechanism will be interesting with regards to early and late onset neurodegeneration, and perhaps how these pathways could be manipulated to delay the onset of disease.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Material</label><media xlink:href="EMS158021-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d23aAdDbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S8"><title>Acknowledgments</title><p>We gratefully acknowledge access and support of the Wolfson Bioimaging Facility for imaging, and the University of Bristol FACS facility for seahorse analysis. Many thanks to Drs Stephen Cross and Richard Seager for image analysis support and advice. We acknowledge the University of Bristol Animal Services Unit for animal support.</p><sec id="S9"><title>Funding</title><p>This work was funded by the Welcome Trust: to HIN through the Wellcome Trust Dynamic Molecular Cell Biology PhD programme (083474) and IC by a Wellcome Investigator award (104632).</p><p>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</p></sec></ack><sec id="S10" sec-type="data-availability"><title>Data and materials availability</title><p id="P25">All data are available in the main text or the supplementary materials.</p></sec><fn-group><fn fn-type="con" id="FN1"><p id="P26"><bold>Author contribution</bold></p><p id="P27">HIN, JMH and IC designed experiments; HIN conducted all experiments; KAW generated Tau constructs; HIN, JMH and IC wrote the manuscript; IC and JMH secured funding and led the project.</p></fn><fn id="FN2" fn-type="conflict"><p id="P28"><bold>Declaration</bold></p><p id="P29">The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguer</surname><given-names>C</given-names></name><name><surname>Gambarotta</surname><given-names>D</given-names></name><name><surname>Mailloux</surname><given-names>RJ</given-names></name><name><surname>Moffat</surname><given-names>C</given-names></name><name><surname>Dent</surname><given-names>R</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Harper</surname><given-names>ME</given-names></name></person-group><article-title>Galactose Enhances Oxidative Metabolism and Reveals Mitochondrial Dysfunction in Human Primary Muscle Cells</article-title><source>Plos One</source><year>2011</year><volume>6</volume><issue>12</issue><fpage>11</fpage><elocation-id>e28536</elocation-id><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC3240634</pub-id><pub-id pub-id-type="pmid">22194845</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0028536</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>J</given-names></name><name><surname>Lucas</surname><given-names>JJ</given-names></name><name><surname>Perez</surname><given-names>M</given-names></name><name><surname>Hernandez</surname><given-names>F</given-names></name></person-group><article-title>Role of tau protein in both physiological and pathological conditions</article-title><source>Physiological Reviews</source><year>2004</year><volume>84</volume><issue>2</issue><fpage>361</fpage><lpage>384</lpage><comment>[Review]</comment><pub-id pub-id-type="pmid">15044677</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Ziv</surname><given-names>R</given-names></name><name><surname>Bolas</surname><given-names>T</given-names></name><name><surname>Dillin</surname><given-names>A</given-names></name></person-group><article-title>Systemic effects of mitochondrial stress</article-title><source>Embo Reports</source><year>2020</year><volume>21</volume><issue>6</issue><fpage>15</fpage><elocation-id>e50094</elocation-id><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC7271648</pub-id><pub-id pub-id-type="pmid">32449292</pub-id><pub-id pub-id-type="doi">10.15252/embr.202050094</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbier</surname><given-names>P</given-names></name><name><surname>Zejneli</surname><given-names>O</given-names></name><name><surname>Martinho</surname><given-names>M</given-names></name><name><surname>Lasorsa</surname><given-names>A</given-names></name><name><surname>Belle</surname><given-names>V</given-names></name><name><surname>Smet-Nocca</surname><given-names>C</given-names></name><etal/><name><surname>Landrieu</surname><given-names>I</given-names></name></person-group><article-title>Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects</article-title><source>Frontiers in Aging Neuroscience</source><year>2019</year><volume>11</volume><fpage>204</fpage><comment>14</comment><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC6692637</pub-id><pub-id pub-id-type="pmid">31447664</pub-id><pub-id pub-id-type="doi">10.3389/fnagi.2019.00204</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>LI</given-names></name><name><surname>Frankfurter</surname><given-names>A</given-names></name><name><surname>Rebhun</surname><given-names>LI</given-names></name></person-group><article-title>THE DISTRIBUTION OF TAU IN THE MAMMALIAN CENTRAL NERVOUS-SYSTEM</article-title><source>Journal of Cell Biology</source><year>1985</year><volume>101</volume><issue>4</issue><fpage>1371</fpage><lpage>1378</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC2113928</pub-id><pub-id pub-id-type="pmid">3930508</pub-id><pub-id pub-id-type="doi">10.1083/jcb.101.4.1371</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittins</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>TNT-Induced Phagocytosis: Tunneling Nanotubes Mediate the Transfer of Pro-Phagocytic Signals From Apoptotic to Viable Cells</article-title><source>Journal of Cellular Physiology</source><year>2017</year><volume>232</volume><issue>9</issue><fpage>2271</fpage><lpage>2279</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC5485076</pub-id><pub-id pub-id-type="pmid">27591547</pub-id><pub-id pub-id-type="doi">10.1002/jcp.25584</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>MM</given-names></name><name><surname>Slaughter</surname><given-names>T</given-names></name><name><surname>Moshiach</surname><given-names>S</given-names></name><name><surname>Obrocka</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>I</given-names></name></person-group><article-title>Tau is enriched on dynamic microtubules in the distal region of growing axons</article-title><source>Journal of Neuroscience</source><year>1996</year><volume>16</volume><issue>11</issue><fpage>3601</fpage><lpage>3619</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC6578833</pub-id><pub-id pub-id-type="pmid">8642405</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-11-03601.1996</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadhead</surname><given-names>MJ</given-names></name><name><surname>Horrocks</surname><given-names>MH</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Muresan</surname><given-names>L</given-names></name><name><surname>Benavides-Piccione</surname><given-names>R</given-names></name><name><surname>DeFelipe</surname><given-names>J</given-names></name><etal/><name><surname>Grant</surname><given-names>SGN</given-names></name></person-group><article-title>PSD95 nanoclusters are postsynaptic building blocks in hippocampus circuits</article-title><source>Scientific Reports</source><year>2016</year><volume>6</volume><fpage>14</fpage><elocation-id>24626</elocation-id><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC4842999</pub-id><pub-id pub-id-type="pmid">27109929</pub-id><pub-id pub-id-type="doi">10.1038/srep24626</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacinska</surname><given-names>A</given-names></name><name><surname>Koehler</surname><given-names>CM</given-names></name><name><surname>Milenkovic</surname><given-names>D</given-names></name><name><surname>Lithgow</surname><given-names>T</given-names></name><name><surname>Pfanner</surname><given-names>N</given-names></name></person-group><article-title>Importing Mitochondrial Proteins: Machineries and Mechanisms</article-title><source>Cell</source><year>2009</year><volume>138</volume><issue>4</issue><fpage>628</fpage><lpage>644</lpage><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC4099469</pub-id><pub-id pub-id-type="pmid">19703392</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2009.08.005</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacinska</surname><given-names>A</given-names></name><name><surname>Rehling</surname><given-names>P</given-names></name><name><surname>Guiard</surname><given-names>B</given-names></name><name><surname>Frazier</surname><given-names>AE</given-names></name><name><surname>Schulze-Specking</surname><given-names>A</given-names></name><name><surname>Pfanner</surname><given-names>N</given-names></name><etal/><name><surname>Meisinger</surname><given-names>C</given-names></name></person-group><article-title>Mitochondrial translocation contact sites: separation of dynamic and stabilizing elements in formation of a TOM-TIM-preprotein supercomplex</article-title><source>Embo Journal</source><year>2003</year><volume>22</volume><issue>20</issue><fpage>5370</fpage><lpage>5381</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC213786</pub-id><pub-id pub-id-type="pmid">14532110</pub-id><pub-id pub-id-type="doi">10.1093/emboj/cdg532</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhary</surname><given-names>AR</given-names></name><name><surname>Berger</surname><given-names>F</given-names></name><name><surname>Berger</surname><given-names>CL</given-names></name><name><surname>Hendricks</surname><given-names>AG</given-names></name></person-group><article-title>Tau directs intracellular trafficking by regulating the forces exerted by kinesin and dynein teams</article-title><source>Traffic</source><year>2018</year><volume>19</volume><issue>2</issue><fpage>111</fpage><lpage>121</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC5783771</pub-id><pub-id pub-id-type="pmid">29077261</pub-id><pub-id pub-id-type="doi">10.1111/tra.12537</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XB</given-names></name><name><surname>Nelson</surname><given-names>CD</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Winters</surname><given-names>CA</given-names></name><name><surname>Azzam</surname><given-names>R</given-names></name><name><surname>Sousa</surname><given-names>AA</given-names></name><etal/><name><surname>Reese</surname><given-names>TS</given-names></name></person-group><article-title>PSD-95 Is Required to Sustain the Molecular Organization of the Postsynaptic Density</article-title><source>Journal of Neuroscience</source><year>2011</year><volume>31</volume><issue>17</issue><fpage>6329</fpage><lpage>6338</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC3099547</pub-id><pub-id pub-id-type="pmid">21525273</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5968-10.2011</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>TMJ</given-names></name></person-group><source>A small molecule dissociates the PAM motor from the TIM23 channel</source><publisher-name>University of California Los Angeles</publisher-name><year>2017</year><comment>[Article]</comment></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cieri</surname><given-names>D</given-names></name><name><surname>Vicario</surname><given-names>M</given-names></name><name><surname>Vallese</surname><given-names>F</given-names></name><name><surname>D’Orsi</surname><given-names>B</given-names></name><name><surname>Berto</surname><given-names>P</given-names></name><name><surname>Grinzato</surname><given-names>A</given-names></name><etal/><name><surname>Cali</surname><given-names>T</given-names></name></person-group><article-title>Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca2+ handling</article-title><source>Biochimica Et Biophysica Acta-Molecular Basis of Disease</source><year>2018</year><volume>1864</volume><issue>10</issue><fpage>3247</fpage><lpage>3256</lpage><comment>[Article]</comment><pub-id pub-id-type="pmid">30006151</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>MP</given-names></name><name><surname>Perry</surname><given-names>VH</given-names></name></person-group><article-title>Axon pathology in neurological disease: a neglected therapeutic target</article-title><source>Trends in Neurosciences</source><year>2002</year><volume>25</volume><issue>10</issue><fpage>532</fpage><lpage>537</lpage><elocation-id>s0166-2236(02)02255-5</elocation-id><comment>Pii [Review]</comment><pub-id pub-id-type="pmid">12220882</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Creed</surname><given-names>S</given-names></name><name><surname>McKenzie</surname><given-names>M</given-names></name></person-group><chapter-title>Measurement of Mitochondrial Membrane Potential with the Fluorescent Dye Tetramethylrhodamine Methyl Ester (TMRM)</chapter-title><person-group person-group-type="editor"><name><surname>Haznadar</surname><given-names>M</given-names></name></person-group><source>Cancer Metabolism: Methods and Protocols</source><publisher-name>Springer</publisher-name><publisher-loc>New York</publisher-loc><year>2019</year><fpage>69</fpage><lpage>76</lpage><comment>[Article]</comment><pub-id pub-id-type="pmid">30725451</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>S</given-names></name></person-group><source>miaanalysis/mia: Version 0210</source><year>2021</year><comment>Retrieved 18<sup>th</sup> January from</comment><comment>[Article]</comment></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>S</given-names></name><name><surname>Seager</surname><given-names>R</given-names></name></person-group><article-title>Colocalisation analysis macros and workflows</article-title><year>2022</year><comment>[Article]</comment></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>L</given-names></name><name><surname>Prabhu</surname><given-names>BM</given-names></name><name><surname>Galati</surname><given-names>DF</given-names></name><name><surname>Avadhani</surname><given-names>NG</given-names></name><name><surname>Anandatheerthavarada</surname><given-names>HK</given-names></name></person-group><article-title>Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction</article-title><source>Journal of Neuroscience</source><year>2006</year><volume>26</volume><issue>35</issue><fpage>9057</fpage><lpage>9068</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC6675337</pub-id><pub-id pub-id-type="pmid">16943564</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1469-06.2006</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>L</given-names></name><name><surname>Raghavendran</surname><given-names>V</given-names></name><name><surname>Prabhu</surname><given-names>BM</given-names></name><name><surname>Avadhani</surname><given-names>NG</given-names></name><name><surname>Anandatheerthavarada</surname><given-names>HK</given-names></name></person-group><article-title>Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain</article-title><source>Journal of Biological Chemistry</source><year>2008</year><volume>283</volume><issue>14</issue><fpage>9089</fpage><lpage>9100</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC2431021</pub-id><pub-id pub-id-type="pmid">18245082</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M710012200</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>R</given-names></name><name><surname>Ross</surname><given-names>JL</given-names></name><name><surname>Goldman</surname><given-names>YE</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><article-title>Differential regulation of dynein and kinesin motor proteins by tau</article-title><source>Science</source><year>2008</year><volume>319</volume><issue>5866</issue><fpage>1086</fpage><lpage>1089</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC2866193</pub-id><pub-id pub-id-type="pmid">18202255</pub-id><pub-id pub-id-type="doi">10.1126/science.1152993</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebneth</surname><given-names>A</given-names></name><name><surname>Godemann</surname><given-names>R</given-names></name><name><surname>Stamer</surname><given-names>K</given-names></name><name><surname>Illenberger</surname><given-names>S</given-names></name><name><surname>Trinczek</surname><given-names>B</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer’s disease</article-title><source>Journal of Cell Biology</source><year>1998</year><volume>143</volume><issue>3</issue><fpage>777</fpage><lpage>794</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC2148132</pub-id><pub-id pub-id-type="pmid">9813097</pub-id><pub-id pub-id-type="doi">10.1083/jcb.143.3.777</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>HC</given-names></name><name><surname>Allen</surname><given-names>WJ</given-names></name><name><surname>Pereira</surname><given-names>GC</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Dillingham</surname><given-names>MS</given-names></name><name><surname>Collinson</surname><given-names>I</given-names></name></person-group><article-title>Towards a molecular mechanism underlying mitochondrial protein import through the TOM and TIM23 complexes</article-title><source>Elife</source><year>2022</year><volume>11</volume><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC9255969</pub-id><pub-id pub-id-type="pmid">35674314</pub-id><pub-id pub-id-type="doi">10.7554/eLife.75426</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name></person-group><article-title>Mutations causing neurodegenerative tauopathies</article-title><source>Biochimica Et Biophysica Acta-Molecular Basis of Disease</source><year>2005</year><volume>1739</volume><issue>2-3</issue><fpage>240</fpage><lpage>250</lpage><comment>[Review]</comment><pub-id pub-id-type="pmid">15615642</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabrucker</surname><given-names>A</given-names></name><name><surname>Vaida</surname><given-names>B</given-names></name><name><surname>Bockmann</surname><given-names>J</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name></person-group><article-title>Synaptogenesis of hippocampal neurons in primary cell culture</article-title><source>Cell and Tissue Research</source><year>2009</year><volume>338</volume><issue>3</issue><fpage>333</fpage><lpage>341</lpage><comment>[Article]</comment><pub-id pub-id-type="pmid">19885679</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubb</surname><given-names>MS</given-names></name><name><surname>Burrone</surname><given-names>J</given-names></name></person-group><article-title>Building and maintaining the axon initial segment</article-title><source>Current Opinion in Neurobiology</source><year>2010</year><volume>20</volume><issue>4</issue><fpage>481</fpage><lpage>488</lpage><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC3191460</pub-id><pub-id pub-id-type="pmid">20537529</pub-id><pub-id pub-id-type="doi">10.1016/j.conb.2010.04.012</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Noble</surname><given-names>W</given-names></name><name><surname>Hanger</surname><given-names>DP</given-names></name></person-group><article-title>Roles of tau protein in health and disease</article-title><source>Acta Neuropathologica</source><year>2017</year><volume>133</volume><issue>5</issue><fpage>665</fpage><lpage>704</lpage><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC5390006</pub-id><pub-id pub-id-type="pmid">28386764</pub-id><pub-id pub-id-type="doi">10.1007/s00401-017-1707-9</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harbauer</surname><given-names>AB</given-names></name><name><surname>Zahedi</surname><given-names>RP</given-names></name><name><surname>Sickmann</surname><given-names>A</given-names></name><name><surname>Pfanner</surname><given-names>N</given-names></name><name><surname>Meisinger</surname><given-names>C</given-names></name></person-group><article-title>The Protein Import Machinery of Mitochondria-A Regulatory Hub in Metabolism, Stress, and Disease</article-title><source>Cell Metabolism</source><year>2014</year><volume>19</volume><issue>3</issue><fpage>357</fpage><lpage>372</lpage><comment>[Review]</comment><pub-id pub-id-type="pmid">24561263</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>XC</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>XN</given-names></name><name><surname>Liu</surname><given-names>XP</given-names></name><etal/><name><surname>Liu</surname><given-names>GP</given-names></name></person-group><article-title>Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><issue>14</issue><fpage>17356</fpage><lpage>17368</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC4951217</pub-id><pub-id pub-id-type="pmid">26943044</pub-id><pub-id pub-id-type="doi">10.18632/oncotarget.7861</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Ranjan</surname><given-names>P</given-names></name><name><surname>Metcalfe</surname><given-names>MG</given-names></name><name><surname>Cao</surname><given-names>WP</given-names></name><name><surname>Mishina</surname><given-names>M</given-names></name><etal/><name><surname>Sambhara</surname><given-names>S</given-names></name></person-group><article-title>Influenza virus exploits tunneling nanotubes for cell-to-cell spread</article-title><source>Scientific Reports</source><year>2017</year><volume>7</volume><fpage>14</fpage><elocation-id>40360</elocation-id><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC5216422</pub-id><pub-id pub-id-type="pmid">28059146</pub-id><pub-id pub-id-type="doi">10.1038/srep40360</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kweon</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name></person-group><article-title>The cellular basis of dendrite pathology in neurodegenerative diseases</article-title><source>Bmb Reports</source><year>2017</year><volume>50</volume><issue>1</issue><fpage>5</fpage><lpage>11</lpage><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC5319658</pub-id><pub-id pub-id-type="pmid">27502014</pub-id><pub-id pub-id-type="doi">10.5483/BMBRep.2017.50.1.131</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaBarbera</surname><given-names>KM</given-names></name><name><surname>Limegrover</surname><given-names>C</given-names></name><name><surname>Rehak</surname><given-names>C</given-names></name><name><surname>Yurko</surname><given-names>R</given-names></name><name><surname>Izzo</surname><given-names>NJ</given-names></name><name><surname>Knezovich</surname><given-names>N</given-names></name><etal/><name><surname>Catalano</surname><given-names>SM</given-names></name></person-group><article-title>Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery</article-title><source>Journal of Neuroscience Methods</source><year>2021</year><volume>358</volume><fpage>9</fpage><elocation-id>109180</elocation-id><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC8217273</pub-id><pub-id pub-id-type="pmid">33836174</pub-id><pub-id pub-id-type="doi">10.1016/j.jneumeth.2021.109180</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasagna-Reeves</surname><given-names>CA</given-names></name><name><surname>Castillo-Carranza</surname><given-names>DL</given-names></name><name><surname>Sengupta</surname><given-names>U</given-names></name><name><surname>Clos</surname><given-names>AL</given-names></name><name><surname>Jackson</surname><given-names>GR</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name></person-group><article-title>Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice</article-title><source>Molecular Neurodegeneration</source><year>2011</year><volume>6</volume><fpage>39</fpage><comment>14</comment><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC3224595</pub-id><pub-id pub-id-type="pmid">21645391</pub-id><pub-id pub-id-type="doi">10.1186/1750-1326-6-39</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>XH</given-names></name><name><surname>Bochner</surname><given-names>BR</given-names></name></person-group><article-title>Optimization of cell permeabilization in electron flow based mitochondrial function assays</article-title><source>Free Radical Biology and Medicine</source><year>2021</year><volume>177</volume><fpage>48</fpage><lpage>57</lpage><comment>[Article]</comment><pub-id pub-id-type="pmid">34656699</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XC</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>XP</given-names></name><etal/><name><surname>Wang</surname><given-names>JZ</given-names></name></person-group><article-title>Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins</article-title><source>Scientific Reports</source><year>2016</year><volume>6</volume><fpage>10</fpage><elocation-id>24756</elocation-id><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC4838862</pub-id><pub-id pub-id-type="pmid">27099072</pub-id><pub-id pub-id-type="doi">10.1038/srep24756</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>MT</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</article-title><source>Nature</source><year>2006</year><volume>443</volume><issue>7113</issue><fpage>787</fpage><lpage>795</lpage><comment>[Review]</comment><pub-id pub-id-type="pmid">17051205</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DL</given-names></name><name><surname>Gao</surname><given-names>YS</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>YG</given-names></name><name><surname>Yin</surname><given-names>JH</given-names></name><name><surname>Feng</surname><given-names>YY</given-names></name><etal/><name><surname>Gao</surname><given-names>JJ</given-names></name></person-group><article-title>Intercellular mitochondrial transfer as a means of tissue revitalization</article-title><source>Signal Transduction and Targeted Therapy</source><year>2021</year><volume>6</volume><issue>1</issue><fpage>65</fpage><comment>18</comment><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC7884415</pub-id><pub-id pub-id-type="pmid">33589598</pub-id><pub-id pub-id-type="doi">10.1038/s41392-020-00440-z</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchetti</surname><given-names>F</given-names></name><name><surname>Canonico</surname><given-names>B</given-names></name><name><surname>Arcangeletti</surname><given-names>M</given-names></name><name><surname>Guescini</surname><given-names>M</given-names></name><name><surname>Cesarini</surname><given-names>E</given-names></name><name><surname>Stocchi</surname><given-names>V</given-names></name><etal/><name><surname>Papa</surname><given-names>S</given-names></name></person-group><article-title>Fas Signalling Promotes Intercellular Communication in T Cells</article-title><source>Plos One</source><year>2012</year><volume>7</volume><issue>4</issue><fpage>12</fpage><elocation-id>35766</elocation-id><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC3338457</pub-id><pub-id pub-id-type="pmid">22558220</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0035766</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Thies</surname><given-names>E</given-names></name><name><surname>Trinczek</surname><given-names>B</given-names></name><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>MARK/PAR1 kinase is a regulator of microtubuledependent transport in axons</article-title><source>Journal of Cell Biology</source><year>2004</year><volume>167</volume><issue>1</issue><fpage>99</fpage><lpage>110</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC2172520</pub-id><pub-id pub-id-type="pmid">15466480</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200401085</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name></person-group><article-title>Activity-dependent endocytic sorting of kainate receptors to recycling or degradation pathways</article-title><source>Embo Journal</source><year>2004</year><volume>23</volume><issue>24</issue><fpage>4749</fpage><lpage>4759</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC535095</pub-id><pub-id pub-id-type="pmid">15549132</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7600483</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Paitel</surname><given-names>E</given-names></name><name><surname>Kawarabayashi</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Chishti</surname><given-names>MA</given-names></name><name><surname>Janus</surname><given-names>C</given-names></name><etal/><name><surname>Shoji</surname><given-names>M</given-names></name></person-group><article-title>Cortical neuronal and glial pathology in TgTau(P301L) transgenic mice - Neuronal degeneration, memory disturbance, and phenotypic variation</article-title><source>American Journal of Pathology</source><year>2006</year><volume>169</volume><issue>4</issue><fpage>1365</fpage><lpage>1375</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC1698843</pub-id><pub-id pub-id-type="pmid">17003492</pub-id><pub-id pub-id-type="doi">10.2353/ajpath.2006.051250</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Needs</surname><given-names>HI</given-names></name><name><surname>Pereira</surname><given-names>GC</given-names></name><name><surname>Glover</surname><given-names>E</given-names></name><name><surname>Hübner</surname><given-names>W</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name><name><surname>Collinson</surname><given-names>I</given-names></name></person-group><article-title>Intercellular Mitochondrial Transfer as a Rescue Mechanism in Response to Protein Import Failure</article-title><source>bioRxiv</source><year>2022</year><elocation-id>2022.2011.2030.518494</elocation-id><comment>[Article]</comment><pub-id pub-id-type="doi">10.1101/2022.11.30.518494</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Needs</surname><given-names>HI</given-names></name><name><surname>Pereira</surname><given-names>GC</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name><name><surname>Collinson</surname><given-names>I</given-names></name></person-group><article-title>The NanoLuc Assay System for Accurate Real-Time Monitoring of Mitochondrial Protein Import within Intact Mammalian Cells</article-title><source>bioRxiv</source><year>2022</year><elocation-id>2022.2009.2023.509159</elocation-id><comment>[Article]</comment><pub-id pub-id-type="doi">10.1101/2022.09.23.509159</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Needs</surname><given-names>HI</given-names></name><name><surname>Protasoni</surname><given-names>M</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name><name><surname>Prudent</surname><given-names>J</given-names></name><name><surname>Collinson</surname><given-names>I</given-names></name><name><surname>Pereira</surname><given-names>GC</given-names></name></person-group><article-title>Interplay between Mitochondrial Protein Import and Respiratory Complexes Assembly in Neuronal Health and Degeneration</article-title><source>Life-Basel</source><year>2021</year><volume>11</volume><issue>5</issue><fpage>432</fpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC8151517</pub-id><pub-id pub-id-type="pmid">34064758</pub-id><pub-id pub-id-type="doi">10.3390/life11050432</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>GC</given-names></name><name><surname>Allen</surname><given-names>WJ</given-names></name><name><surname>Watkins</surname><given-names>DW</given-names></name><name><surname>Buddrus</surname><given-names>L</given-names></name><name><surname>Noone</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal/><name><surname>Collinson</surname><given-names>I</given-names></name></person-group><article-title>A High-Resolution Luminescent Assay for Rapid and Continuous Monitoring of Protein Translocation across Biological Membranes</article-title><source>Journal of Molecular Biology</source><year>2019</year><volume>431</volume><issue>8</issue><fpage>1689</fpage><lpage>1699</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC6461198</pub-id><pub-id pub-id-type="pmid">30878481</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2019.03.007</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poorkaj</surname><given-names>P</given-names></name><name><surname>Grossman</surname><given-names>M</given-names></name><name><surname>Steinbart</surname><given-names>E</given-names></name><name><surname>Payami</surname><given-names>H</given-names></name><name><surname>Sadovnick</surname><given-names>A</given-names></name><name><surname>Nochlin</surname><given-names>D</given-names></name><etal/><name><surname>Bird</surname><given-names>TD</given-names></name></person-group><article-title>Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia</article-title><source>Archives of Neurology</source><year>2001</year><volume>58</volume><issue>3</issue><fpage>383</fpage><lpage>387</lpage><comment>[Article]</comment><pub-id pub-id-type="pmid">11255441</pub-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rueden</surname><given-names>CT</given-names></name><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Hiner</surname><given-names>MC</given-names></name><name><surname>DeZonia</surname><given-names>BE</given-names></name><name><surname>Walter</surname><given-names>AE</given-names></name><name><surname>Arena</surname><given-names>ET</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><article-title>ImageJ2: ImageJ for the next generation of scientific image data</article-title><source>Bmc Bioinformatics</source><year>2017</year><volume>18</volume><fpage>529</fpage><comment>26</comment><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC5708080</pub-id><pub-id pub-id-type="pmid">29187165</pub-id><pub-id pub-id-type="doi">10.1186/s12859-017-1934-z</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><etal/><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><year>2012</year><volume>9</volume><issue>7</issue><fpage>676</fpage><lpage>682</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC3855844</pub-id><pub-id pub-id-type="pmid">22743772</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schon</surname><given-names>EA</given-names></name><name><surname>Przedborski</surname><given-names>S</given-names></name></person-group><article-title>Mitochondria: The Next (Neurode)Generation</article-title><source>Neuron</source><year>2011</year><volume>70</volume><issue>6</issue><fpage>1033</fpage><lpage>1053</lpage><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC3407575</pub-id><pub-id pub-id-type="pmid">21689593</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2011.06.003</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Seager</surname><given-names>RA</given-names></name></person-group><source>Investigating the role of SUMOylation of Mitochondrial Fission Factor in Mitochondrial Dynamics</source><publisher-name>University of Bristol</publisher-name><year>2020</year><comment>[Article]</comment></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokol</surname><given-names>AM</given-names></name><name><surname>Sztolsztener</surname><given-names>ME</given-names></name><name><surname>Wasilewski</surname><given-names>M</given-names></name><name><surname>Heinz</surname><given-names>E</given-names></name><name><surname>Chacinska</surname><given-names>A</given-names></name></person-group><article-title>Mitochondrial protein translocases for survival and wellbeing</article-title><source>Febs Letters</source><year>2014</year><volume>588</volume><issue>15</issue><fpage>2484</fpage><lpage>2495</lpage><comment>[Review]</comment><pub-id pub-id-type="pmid">24866464</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamer</surname><given-names>K</given-names></name><name><surname>Vogel</surname><given-names>R</given-names></name><name><surname>Thies</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><article-title>Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress</article-title><source>Journal of Cell Biology</source><year>2002</year><volume>156</volume><issue>6</issue><fpage>1051</fpage><lpage>1063</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC2173473</pub-id><pub-id pub-id-type="pmid">11901170</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200108057</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>L</given-names></name><name><surname>Eckert</surname><given-names>A</given-names></name><name><surname>Grimm</surname><given-names>A</given-names></name></person-group><article-title>Insights into Disease-Associated Tau Impact on Mitochondria</article-title><source>International Journal of Molecular Sciences</source><year>2020</year><volume>21</volume><issue>17</issue><fpage>27</fpage><elocation-id>6344</elocation-id><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC7503371</pub-id><pub-id pub-id-type="pmid">32882957</pub-id><pub-id pub-id-type="doi">10.3390/ijms21176344</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapia-Rojas</surname><given-names>C</given-names></name><name><surname>Cabezas-Opazo</surname><given-names>F</given-names></name><name><surname>Deaton</surname><given-names>CA</given-names></name><name><surname>Vergara</surname><given-names>EH</given-names></name><name><surname>Johnson</surname><given-names>GVW</given-names></name><name><surname>Quintanilla</surname><given-names>RA</given-names></name></person-group><article-title>It’s all about tau</article-title><source>Progress in Neurobiology</source><year>2019</year><volume>175</volume><fpage>54</fpage><lpage>76</lpage><comment>[Review]</comment><pub-id pub-id-type="pmcid">PMC6397676</pub-id><pub-id pub-id-type="pmid">30605723</pub-id><pub-id pub-id-type="doi">10.1016/j.pneurobio.2018.12.005</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardivel</surname><given-names>M</given-names></name><name><surname>Begard</surname><given-names>S</given-names></name><name><surname>Bousset</surname><given-names>L</given-names></name><name><surname>Dujardin</surname><given-names>S</given-names></name><name><surname>Coens</surname><given-names>A</given-names></name><name><surname>Melki</surname><given-names>R</given-names></name><name><surname>Colin</surname><given-names>M</given-names></name></person-group><article-title>Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies</article-title><source>Acta Neuropathologica Communications</source><year>2016</year><volume>4</volume><fpage>117</fpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC5096005</pub-id><pub-id pub-id-type="pmid">27809932</pub-id><pub-id pub-id-type="doi">10.1186/s40478-016-0386-4</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>E</given-names></name></person-group><article-title>Cryo-EM structure of the mitochondrial protein-import channel TOM complex at near-atomic resolution</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2019</year><volume>26</volume><issue>12</issue><fpage>1158</fpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC8439582</pub-id><pub-id pub-id-type="pmid">31740857</pub-id><pub-id pub-id-type="doi">10.1038/s41594-019-0339-2</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>AJ</given-names></name><name><surname>Maddalena</surname><given-names>LA</given-names></name><name><surname>Robb</surname><given-names>EL</given-names></name><name><surname>Moradi</surname><given-names>F</given-names></name><name><surname>Stuart</surname><given-names>JA</given-names></name></person-group><article-title>A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture</article-title><source>Acta Histochemica</source><year>2017</year><volume>119</volume><issue>3</issue><fpage>315</fpage><lpage>326</lpage><comment>[Article]</comment><pub-id pub-id-type="pmid">28314612</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>TM</given-names></name><name><surname>Parson</surname><given-names>SH</given-names></name><name><surname>Gillingwater</surname><given-names>TH</given-names></name></person-group><article-title>Synaptic vulnerability in neurodegenerative disease</article-title><source>Journal of Neuropathology and Experimental Neurology</source><year>2006</year><volume>65</volume><issue>8</issue><fpage>733</fpage><lpage>739</lpage><comment>[Review]</comment><pub-id pub-id-type="pmid">16896307</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witman</surname><given-names>GB</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name><name><surname>Weingarten</surname><given-names>MD</given-names></name><name><surname>Kirschner</surname><given-names>MW</given-names></name></person-group><article-title>TUBULIN REQUIRES TAU FOR GROWTH ONTO MICROTUBULE INITIATING SITES</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1976</year><volume>73</volume><issue>11</issue><fpage>4070</fpage><lpage>4074</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC431332</pub-id><pub-id pub-id-type="pmid">1069293</pub-id><pub-id pub-id-type="doi">10.1073/pnas.73.11.4070</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>H</given-names></name><name><surname>Baranov</surname><given-names>SV</given-names></name><name><surname>Baranova</surname><given-names>OV</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>YC</given-names></name><name><surname>Yablonska</surname><given-names>S</given-names></name><etal/><name><surname>Friedlander</surname><given-names>RM</given-names></name></person-group><article-title>Inhibition of mitochondrial protein import by mutant huntingtin</article-title><source>Nature Neuroscience</source><year>2014</year><volume>17</volume><issue>6</issue><fpage>822</fpage><lpage>831</lpage><comment>[Article]</comment><pub-id pub-id-type="pmcid">PMC4174557</pub-id><pub-id pub-id-type="pmid">24836077</pub-id><pub-id pub-id-type="doi">10.1038/nn.3721</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig 1</label><caption><title>Tau<sup>P301L</sup> associates with the mitochondrial translocation machinery and alters mitochondrial morphology</title><p><bold>(A)</bold> Representative Western blots showing relative protein abundance in mitochondrial and cytosolic fractions of HeLaGAL cells expressing GFP, Myc-Tau<sup>WT</sup> or Myc-Tau<sup>P301L</sup>. Localisation of GFP, Tau<sup>WT</sup> and Tau<sup>P301L</sup> was analysed by probing for GFP (Sigma; G1544) or Myc (CST; 2276). Translocase subunit abundance was analysed by probing for TIM23 (Invitrogen; PA5-71877), TOM40 (Thermo; PA5-57575), and TOM20 (Santa Cruz Biotechnology; sc-17764). ATP5A (Abcam; 15H4C4) and β-actin (Sigma; A2228) were used as loading controls for mitochondria and cytosol, respectively. N=4 (GFP/Myc) and N=3 (translocases) biological replicates.</p><p><bold>(B)</bold> Quantification of the percentage of GFP, Tau<sup>WT</sup> or Tau<sup>P301L</sup> in mitochondrial fraction. Normalised to loading controls. Error bars show SD. One-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(C)</bold> Quantification of translocase subunits (TIM23, TOM40, TOM20). Normalised to loading controls. Error bars show SD. One-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(D)</bold> Representative Western blot showing TOM40 association with Tau<sup>P301L</sup>, but not with Myc-tagged GFP or Tau<sup>WT</sup>, in mitochondrial fraction of HeLaGAL cells. Mitochondria were isolated from HeLaGAL cells expressing Myc-GFP, Myc-Tau<sup>WT</sup>, or Myc-Tau<sup>P301L</sup> and proteins lysed with GDN (input), prior to immunoprecipitation using Myc-trap beads (Chromotek). Eluted proteins (pulldown) were analysed by Western blot and probed against TOM40. N=4 biological replicates. Control blot shown in <xref ref-type="supplementary-material" rid="SD1">supplementary Fig. S1</xref>.</p><p><bold>(E)</bold> Maximum import amplitude from NanoLuc import assay on HeLaGAL cells expressing GFP, Tau<sup>WT</sup>, or Tau<sup>P301L</sup>. Bars represent relative maximum mitochondrial import of the precursor protein <italic>Su9-EGFP-pep86</italic> (normalised to eqFP670 expression, max amplitude/run, and control (GFP)). N=3 biological repeats, each with n=3 technical replicates. Error bars display SD. One-way ANOVA with Tukey’s <italic>post hoc</italic> test were used to determine significance. Import traces shown in <xref ref-type="supplementary-material" rid="SD1">supplementary Fig. S2</xref>.</p><p><bold>(F)</bold> Representative confocal images showing mitochondrial morphology in HeLaGAL cells expressing mito-dsRed and GFP (left, grey), Tau<sup>WT</sup> (middle, teal) or Tau<sup>P301L</sup> (right, pink). Top panel shows mito-dsRed (mitochondria) prior to processing. Middle panel shows mitochondria after processing, and bottom panel shows a zoom of an area of mitochondria (highlighted in middle panel yellow box) to give a clear view of mitochondrial morphology. N=5 biological repeats.</p><p><bold>(G)</bold> Quantification of the average number of mitochondrial branches. Representative images shown in <italic>(F)</italic>. Each point represents an individual cell from a separate z-stack. N=20, 24, 23 for different conditions, respectively, taken from 5 independent biological repeats (N=5). Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(H)</bold> Quantification of the maximum number of mitochondrial branches in a network. As in <italic>(G).</italic></p></caption><graphic xlink:href="EMS158021-f001"/></fig><fig id="F2" position="float"><label>Fig 2</label><caption><title>HeLaGAL cells expressing Tau<sup>P301L</sup> form TNTs that contain mitochondria</title><p><bold>(A)</bold> Representative confocal images showing cell morphology of HeLaGLU or HeLaGAL cells subjected to expression of mCherry (red) as well as GFP, Tau<sup>WT</sup>, or Tau<sup>P301L</sup>. White arrow in bottom right panel indicates a TNT. N=4 biological replicates.</p><p><bold>(B)</bold> Quantification of the proportion of cells with protrusions from representative images shown in <italic>(A)</italic>. Error bars show SD. Two-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance. N=4 biological replicates, 20 cells counted per replicate.</p><p><bold>(C)</bold> Representative confocal images showing mitochondrial localisation (mito-dsRed; green) in cells overexpressing Myc-Tau<sup>P301L</sup> (magenta). N=4 biological replicates.</p><p><bold>(D)</bold> Quantification of the percentage of HeLaGAL cells with protrusions following Tau<sup>P301L</sup> overexpression in the presence of TNT inhibitors. HeLaGAL cells were subjected to expression of Tau<sup>P301L</sup>-mScarlet and either untreated (NT; DMSO only) or treated with 50 nM Cytochalasin D or 100 nM Nocodazole for 48 h. N=3 biological replicates, 20 cells counted per replicate. Error bars show SD. One-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance. Representative images shown in <xref ref-type="supplementary-material" rid="SD1">supplementary Fig. S5</xref>.</p></caption><graphic xlink:href="EMS158021-f002"/></fig><fig id="F3" position="float"><label>Fig 3</label><caption><title>Tau<sup>P301L</sup> and precursor trapping reduce neuronal complexity</title><p><bold>(A)</bold> Representative images showing morphology of DIV21 primary hippocampal neurons expressing mCherry (whole cell cytosolic marker; blue; circle used to highlight complexity in second panel down <italic>i.e.,</italic> the number of processes that cross the circle is representative of number of processes per cell) and Myc-tagged GFP, Tau<sup>WT</sup>, or Tau<sup>P301L</sup> (Myc; green), taken by confocal microscopy. Axon initial segments were stained with Ankyrin-G (magenta; highlighted by box in third panel down; NeuroMab 75-146). N=4 biological replicates.</p><p><bold>(B)</bold> Quantification of number of processes per cell for GFP, Tau<sup>WT</sup> and Tau<sup>P301L</sup> expressing neurons. Each data point represents an individual cell (cells were only analysed if the entire cell could be identified separately from surrounding cells). Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(C)</bold> Quantification of axon length for GFP, Tau<sup>WT</sup> and Tau<sup>P301L</sup> expressing neurons. Cells were only analysed if the axon could be clearly identified. Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(D)</bold> Representative confocal images showing the morphology of DIV21 primary hippocampal neurons expressing mCherry (whole cell cytosolic marker; blue; circle used to highlight complexity in second panel down <italic>i.e.,</italic> the number of processes that cross the circle is representative of number of processes per cell) as well as EGFP-DHFR (-MTS; green; top panel) or Su9-EGFP-DHFR (+MTS; green; top panel) in the presence or absence of 100 nM MTX. Axons were stained with Ankyrin-G (magenta; highlighted by box in third panel down). N=5 biological replicates.</p><p><bold>(E)</bold> Quantification of the number of processes per cell in neurons expressing EGFP-DHFR (-MTS) or Su9-EGFP-DHFR (+MTS) in the presence or absence of 100 nM MTX. Each data point represents an individual cell (cells were only analysed if the entire cell could be identified separately from surrounding cells). Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(F)</bold> Quantification of axonal length in neurons expressing EGFP-DHFR (-MTS) or Su9-EGFP-DHFR (+MTS) in the presence or absence of 100 nM MTX. Cells were only analysed if the axon could be clearly identified. Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p></caption><graphic xlink:href="EMS158021-f003"/></fig><fig id="F4" position="float"><label>Fig 4</label><caption><title>Tau<sup>P301L</sup> and precursor trapping reduce synapse abundance</title><p><bold>(A)</bold> Representative confocal images showing synaptic staining of DIV21 primary hippocampal neurons expressing Myc-tagged GFP, Tau<sup>WT</sup>, or Tau<sup>P301L</sup> (Myc; green). PSD95 staining shows synapses (magenta; second panel from top, also shown in zoom; EMD Millipore AB1596). N=5 biological replicates.</p><p><bold>(B)</bold> Quantification of the average number of synapses per 10 μm dendrite for GFP, Tau<sup>WT</sup> and Tau<sup>P301L</sup> expressing neurons. Synapses were counted manually on blinded data. Each data point represents an individual cell. Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p><p><bold>(C)</bold> Representative confocal microscopy images showing synaptic staining of DIV21 primary hippocampal neurons expressing EGFP-DHFR (-MTS) or Su9-EGFP-DHFR (+MTS; EGFP shown in green, top panels) in the absence or presence of 100 nM MTX (−/+MTX). PSD95 staining shows synapses (magenta, second panel from top, also shown in zoom). N=5 biological replicates.</p><p><bold>(D)</bold> Quantification of the average number of synapses per 10 μm dendrite for neurons expressing EGFP-DHFR (-MTS) or Su9-EGFP-DHFR (+MTS) in the presence or absence of 100 nM MTX. Synapses were counted manually on blinded data. Each data point represents an individual cell. Error bars show SD. Nested one-way ANOVA and Tukey’s <italic>post hoc</italic> test were used to determine significance.</p></caption><graphic xlink:href="EMS158021-f004"/></fig></floats-group></article>